In its market debut on later this week, Concord Biotech's shares rose as much as 33.3%, valuing the biopharmaceutical business at more than 103 billion rupees ($1.24 billion)...
In the dynamic world of healthcare, targeted immunotherapy presents an innovative approach, ushering in a new era of precision medicine for various diseases
Venus Remedies Ltd announced later this week that its flagship R&D drug, Elores, has been launched in Oman's USD 1.4 billion pharmaceutical market. "Clinically proven to be one of the best drugs against ICU infections caused by multidrug-resistant...
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has launched a new online application portal for its Small Healthcare Organisations (SHCO) (maximum sanctioned bed strength of 50) Accreditation Programme....
Union Health Minister Mansukh Mandaviya today launched the first-ever WHO Traditional Medicine Global Summit at Gandhinagar's Mahatma Mandir. The meeting is being held on the sidelines of the G20 meeting of health ministers in Gandhinagar...
This ointment is the 0.03 percent generic version of Leo Pharma AS's Protopic1 ointment. Glenmark Pharmaceuticals Inc., USA will oversee the distribution of Glenmark's Tacrolimus ointment, 0.03 percent, in the United States....
Dr. Agarwal's Health Care said this week that it raised $80 million from existing investors Singapore's Temasek and U.S.-based TPG as the Indian eye hospital operator plans to double its hospital count...
Lupin Limited (Lupin) announced the launch of Jeet, a patient support programme dedicated to heart health. The launch of the initiative coincides with India's 77th Independence Day, symbolising freedom from disease-related stress and a journey...
The National Pharmaceutical Pricing Authority (NPPA) has changed the limits in its rules for permitting manufacturers to change once the retail pricing of formulations is approved, allowing the existing marketing entity to produce the medicine...
The US Food & Drug Administration (USFDA) has given Takeda Pharmaceuticals USA Inc's wholly owned subsidiary company, Eugia Pharma Specialities Limited, final approval to produce and market Icatibant Injection, 30 mg/3 mL (10 mg/mL), Single-Dose...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
